Stroke in children with sickle cell disease

Author:

Kirkham Fenella J.,deBaun Michael R.

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical)

Reference117 articles.

1. Earley CJ, Kittner SJ, Feeser BR, et al.: Stroke in children and sickle-cell disease. Neurology 1998, 51:169–176.

2. Scothorn DJ, Price C, Schwartz D, et al.: Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Pediatr 2002, 140:348–354. In a multicenter study of patients receiving blood transfusion for at least 5 years after stroke, the recurrence rate was 2.2 per 100 patient years. None of the patients who had had their first stroke in the context of a medical event had a second stroke after 2 years. For the other patients who had had their first strokes without warning, the recurrence rate was 1.9 per 100 patient years. However, vascular imaging to confirm or exclude moyamoya was not available.

3. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al.: Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998, 91:288–294. Ischemic stroke was more common children and older patients and the risk factors were previous transient ischemic attack, low haemoglobin, recent chest crisis, and hypertension. Intracranial hemorrhage occurred mainly in young adults and the risk factors were low haemoglobin and high leukocyte count.

4. Adams RJ, McKie VC, Carl EM, et al.: Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann Neurol 1997, 42:699–704.

5. Adams RJ: Prevention of stroke by transfusion in sickle cell disease. N Engl J Med 1998, 339:5–11. This randomized controlled trial study of blood transfusion for patients with transcranial Doppler internal carotid or middle cerebral artery velocities greater than 200 cm per sec showed a 92% reduction in the risk of stroke in the treatment arm. However, 10 of 63 patients in the treatment arm dropped out mostly because of alloimmunization or poor compliance.

Cited by 64 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Sickle cell anemia and early stroke detection and prevention in Nigeria;Frontiers in Stroke;2024-06-19

2. 20. Neurological Disorders;Chronic Disease Epidemiology, Prevention, and Control, 5th edition;2023-01

3. Impact of omega-3 fatty acids supplementation in children with sickle cell disease in Saudi Arabia;Journal of King Saud University - Science;2022-06

4. Sickle Cell Disease, a Review;Hemato;2022-05-30

5. Pathophysiology of Vascular Stenosis and Remodeling in Moyamoya Disease;Frontiers in Neurology;2021-09-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3